A Review of Medicare Part D Updates
The Centers for Medicare & Medicaid Services (CMS) is addressing significant coverage gap changes created by the recently-passed Bipartisan Budget Act of 2018, according...
Updates in Biosimilar Legislation and Regulation
To date, 41 states and Puerto Rico have laws for biosimilars. However, federal and state regulations on biosimilars are confusing, incomplete, and often discourage...
The Case for Motivational Interviewing
Motivational interviewing is a direct, patient-centered conversational method that elicits positive change by helping patients explore and resolve ambivalence. The goal is to increase...
Challenges, Goals, and Strategies for the Management of Depression
Major depressive disorder is a complex, chronic, and recurrent illness that can affect other medical conditions. It is projected that 16.2 million Americans live...
The Value of Using Pharmacogenetic Risk Scores in Routine Practice
Conducting genetic tests for variants of drug metabolizing enzyme (DME) is a potential option for personalizing medication prescribing, optimizing patient outcomes, and reducing healthcare...
Both Chronic and Acute Opioid Users Have Increased Healthcare Utilization
Between 2000 and 2015, deaths from opioid prescriptions more than quadrupled, and evidence of long-term efficacy of opioids for chronic pain is limited. Researchers...
Study Compares Cost of Apremilast Versus Biologics for Patients with Psoriasis
Researchers sought to assess real-world costs associated with the oral agent apremilast for the treatment of biologic-naïve and biologic-experienced patients with psoriasis compared with...
Orphan Drug Outlook and the Management of These Agents
The U.S. Food and Drug Administration (FDA) currently has about 200 pending orphan drug designation requests, according to experts at a session on the...
Substantial Costs Associated with Acute Bleeding Events in Hemophilia A
Information on costs related to the treatment of acute bleeding events in patients with hemophilia A is lacking, so researchers evaluated the healthcare resource...
Economic Burden is Higher for Patients with Type 2 Diabetes and Comorbidities
Patients with type 2 diabetes can experience comorbidities that lead to hospitalizations and impact the economic disease burden.
Researchers sought to estimate incremental all-cause healthcare...